A novel U-shaped relationship between mitochondrial mass and risk of incomplete immune reconstitution in HIV-infected patients on antiviral therapy

Mitochondrial mass (MM) is considered an essential parameter of the immune system, but the association of MM with incomplete immune reconstitution (IIR) in people living with HIV (PLWH) remains unclear. Here, we tested 2148 blood samples from 1999 PLWH by flow cytometry in China between August 2021...

Full description

Saved in:
Bibliographic Details
Published in:Clinical immunology (Orlando, Fla.) Vol. 245; p. 109137
Main Authors: Liu, Fang, Yang, Zongxing, Huang, Weiqiang, Zhang, Zhongdong, Shi, Jinchuan, Li, Guoping, Li, Jiamin, Zhang, Wenhui, Zheng, Guoxiang, Yan, Dingyan, Huang, Jinsong, Yu, Jianhua
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-12-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mitochondrial mass (MM) is considered an essential parameter of the immune system, but the association of MM with incomplete immune reconstitution (IIR) in people living with HIV (PLWH) remains unclear. Here, we tested 2148 blood samples from 1999 PLWH by flow cytometry in China between August 2021 and February 2022. A novel U-shaped relationship, determined by multivariable smooth curve fitting and piecewise-linear mixed-effect model, was observed between the ratio of MM to SD (MM/SD) and IIR, with a threshold cutoff of 2.8. For MM/SD <2.8, per SD increment of MM was independently associated with 30%, 30%, 20%, and 20% decreased risk of CD4+ T-cell counts <500 cells/μL after 4 years of treatment and CD4+ T-cell counts <350 cells/μL after 4, 5, 6 years of treatment, respectively. Our study suggested that increasing MM may indicate the low risk of IIR for PLWH with MM/SD <2.8. •A novel U-shaped relation was observed between MM and IIR in HIV-infected patients;•The significant saturated threshold of MM/SD on CD4+ T-cell counts was 2.8;•Increasing MM may indicate the risk of IIR for HIV-infected patients with MM/SD <2.8.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1521-6616
1521-7035
DOI:10.1016/j.clim.2022.109137